Stock-Based Compensation (Tables)

12 Months Ended

Sep. 30, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Activity in the Company's RSUs

A summary of activity in the Company’s RSUs for the year ended September 30, 2025 is as follows:

	Number of units			Weighted- Average Grant Date Fair Value per Unit
Outstanding at September 30, 2024		4,463,253		$	7.93
Issued		11,036,957			0.96
Forfeited		(47,775	)		3.36
Vested		(5,906,427	)		0.96
Outstanding at September 30, 2025		9,546,008			4.21

Schedule of Activity in the Company's RSAs

A summary of activity in the Company’s RSAs for the year ended September 30, 2025 is as follows:

	Number of units			Weighted- Average Grant Date Fair Value per Share
Outstanding at September 30, 2024		—		$	—
Issued		5,100,000			0.70
Vested		(227,500	)		0.70
Outstanding at September 30, 2025		4,872,500			0.70

Schedule of Stock Option Activity

Stock option activity for the year ended September 30, 2025 is as follows:

	Number of Options			Weighted- Average Exercise Price per Share		Weighted- Average Remaining Contractual Term (years)
Outstanding at September 30, 2024		2,740,846		$	4.89
Forfeited		(71,569	)		6.03
Expired		(216,953	)		4.92
Outstanding at September 30, 2025		2,452,324			4.85		5.9
Exercisable at September 30, 2025		2,331,189			4.75		5.8

Schedule of Weighted-Average Grant Date Fair Value of Options Granted

	Year ended September 30, 2024
	Range
	Low			High
Expected volatility		54.8	%		55.6	%
Expected dividend yield		0	%		0	%
Risk-free interest rate		3.9	%		4.4	%
Expected term (years)		4.5			5.3

Schedule of Consolidated Statements of Operations and Comprehensive Loss

The consolidated statements of operations and comprehensive loss include stock-based compensation expense as follows:

	Year ended September 30,
	2025		2024
Cost of revenue – product	$	174	$	15
Cost of revenue – services		9		—
Research and development		338		1,124
Selling, general and administrative		25,098		20,244
Total stock-based compensation expense	$	25,619	$	21,383